| ||||||||||||
|
||||||||||||
Stimulants and Prescription Diet Pills: Also see Data tables on prescription type drugsAlso see All reports on prescription type drugs The New DAWN Report: Emergency Department Visits Involving ADHD Stimulant Medications 2006 NSDUH: Results of the 2006 National Survey on Drug Use & Health (HTML format) 2005 NSDUH: Results of the 2005 National Survey on Drug Use & Health (HTML format) 2004 NSDUH: Detailed Tables on NonMedical Use of Prescription type Drugs
Detailed Tables on NonMedical Use of Prescription type Drugs from 2003 NSDUH:
2000 & 2001 National Household Survey on Drug Abuse: The reports and tables below present data on persons reporting use of the following specific stimulants:
Other reports on prescription-type and over-the-counter (OTC) drugs |
Number (in Thousands) by Age Group and Survey Year (2000 & 2001) |
Table 1.109A Estimated Numbers (in Thousands) of Lifetime Users of Specific Stimulants, by Age Group: 2000 and 2001
Stimulants |
Total |
AGE GROUP (Years) |
||||||
12-17 |
18-25 |
26 or Older |
||||||
2000 |
2001 |
2000 |
2001 |
2000 |
2001 |
2000 |
2001 |
|
Methamphetamine, Desoxyn®, or Methedrine |
8,843 |
9,600 |
305 |
338 |
1,185b |
1,510 |
7,353 |
7,752 |
Prescription Diet Pills1 |
6,605 |
7,004 |
282 |
241 |
548 |
630 |
5,776 |
6,134 |
Ritalin® or Methylphenidate |
2,761b |
3,442 |
506 |
472 |
1,055b |
1,385 |
1,201 |
1,585 |
Cylert® |
246 |
194 |
24 |
20 |
52 |
44 |
169 |
130 |
Dexedrine® |
1,982 |
2,272 |
63 |
68 |
191b |
281 |
1,729 |
1,923 |
Dextroamphetamine |
634 |
494 |
28 |
38 |
77 |
75 |
528 |
381 |
Didrex® |
182 |
165 |
16 |
15 |
20 |
25 |
145 |
125 |
Eskatrol® |
152 |
83 |
11 |
10 |
22 |
3 |
118 |
70 |
Ionamin® |
333 |
322 |
14 |
8 |
41 |
16 |
279 |
297 |
Mazanor® |
93 |
77 |
23 |
16 |
19b |
3 |
51 |
57 |
Obedrin-LA® |
91 |
60 |
5 |
5 |
13 |
7 |
73 |
48 |
Plegine® |
84 |
21 |
12 |
9 |
4 |
9 |
67 |
* |
Preludin® |
671 |
597 |
10 |
13 |
47 |
54 |
614 |
530 |
Sanorex® |
106 |
98 |
18 |
19 |
26 |
32 |
63 |
46 |
Tenuate® |
81 |
134 |
9 |
14 |
18 |
11 |
54 |
110 |
*Low precision; no estimate reported.
aDifference between estimate and 2001 estimate is statistically significant at the .05 level.
bDifference between estimate and 2001 estimate is statistically significant at the .01 level.
1 For example, Amphetamines, Benzedrine®, Biphetamine®, Fastin®, or Phentermine.
Source: SAMHSA, Office of Applied Studies, National Household Survey on Drug Abuse, 2000 and 2001.
Percent by Age Group and Survey Year (2000 & 2001) |
Table 1.109B Percentages Reporting Lifetime Use of Specific Stimulants, by Age Group: 2000 and 2001
Stimulants |
Total |
AGE GROUP (Years) |
||||||
12-17 |
18-25 |
26 or Older |
||||||
2000 |
2001 |
2000 |
2001 |
2000 |
2001 |
2000 |
2001 |
|
Methamphetamine, Desoxyn®, or Methedrine |
4.0 |
4.3 |
1.3 |
1.4 |
4.1b |
5.1 |
4.3 |
4.5 |
Prescription Diet Pills1 |
3.0 |
3.1 |
1.2 |
1.0 |
1.9 |
2.1 |
3.4 |
3.6 |
Ritalin® or Methylphenidate |
1.2b |
1.5 |
2.2 |
2.0 |
3.6b |
4.7 |
0.7 |
0.9 |
Cylert® |
0.1 |
0.1 |
0.1 |
0.1 |
0.2 |
0.1 |
0.1 |
0.1 |
Dexedrine® |
0.9 |
1.0 |
0.3 |
0.3 |
0.7b |
1.0 |
1.0 |
1.1 |
Dextroamphetamine |
0.3 |
0.2 |
0.1 |
0.2 |
0.3 |
0.3 |
0.3 |
0.2 |
Didrex® |
0.1 |
0.1 |
0.1 |
0.1 |
0.1 |
0.1 |
0.1 |
0.1 |
Eskatrol® |
0.1 |
0.0 |
0.0 |
0.0 |
0.1 |
0.0 |
0.1 |
0.0 |
Ionamin® |
0.1 |
0.1 |
0.1 |
0.0 |
0.1 |
0.1 |
0.2 |
0.2 |
Mazanor® |
0.0 |
0.0 |
0.1 |
0.1 |
0.1b |
0.0 |
0.0 |
0.0 |
Obedrin-LA® |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
Plegine® |
0.0 |
0.0 |
0.1 |
0.0 |
0.0 |
0.0 |
0.0 |
* |
Preludin® |
0.3 |
0.3 |
0.0 |
0.1 |
0.2 |
0.2 |
0.4 |
0.3 |
Sanorex® |
0.0 |
0.0 |
0.1 |
0.1 |
0.1 |
0.1 |
0.0 |
0.0 |
Tenuate® |
0.0 |
0.1 |
0.0 |
0.1 |
0.1 |
0.0 |
0.0 |
0.1 |
*Low precision; no estimate reported.
aDifference between estimate and 2001 estimate is statistically significant at the .05 level.
bDifference between estimate and 2001 estimate is statistically significant at the .01 level.
1 For example, Amphetamines, Benzedrine®, Biphetamine®, Fastin®, or Phentermine.
Source: SAMHSA, Office of Applied Studies, National Household Survey on Drug Abuse, 2000 and 2001.
This page was last updated on December 30, 2008. |
SAMHSA, an agency in the Department of Health and Human Services, is the Federal Government's lead agency for improving the quality and availability of substance abuse prevention, addiction treatment, and mental health services in the United States.
* PDF formatted files require that Adobe Acrobat Reader® program is installed on your computer. Click here to download this FREE software now from Adobe. |